Navigation Links
Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
Date:6/12/2008

al generally associated with currently approved GABAergic drugs. Through its novel mechanism, APD125 has the potential to reduce insomnia symptoms by improving sleep maintenance.

About Insomnia

Insomnia is characterized by inadequate or poor sleep due to nonrefreshing sleep, frequent wakening with difficulty falling back to sleep, difficulty falling asleep or waking too early. Most insomnia complaints relate to sleep maintenance issues, such as waking frequently or awakening too early, as opposed to problems with sleep latency (i.e. falling asleep). Between 30 to 40% of US adults report some level of insomnia and insomnia is a chronic problem for about 10% of the US adult population. The lack of restful sleep may impair the person's ability to carry out their daily responsibilities because they are too tired or have trouble concentrating.

Insomnia has a variety of causes. It is often a symptom of some other disease or condition (e.g. life stress, psychiatric and medical disorders, or use of certain medications), but it can also be a distinct disorder. The prevalence of insomnia increases with age and is more common in women. Common symptoms of acute insomnia are sleepiness, negative mood and impairment of performance. Chronic insomnia is often associated with fatigue, mood changes, difficulty concentrating and impaired daytime functioning.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Mer
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
2. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
4. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
5. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
7. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
8. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
9. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
10. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
11. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Conn. , Sept. 1, 2015  Results from ... AD™ study demonstrate that 5g of idarucizumab enabled ... situations involving patients treated with dabigatran (Pradaxa ® ... of the anticoagulant effect of dabigatran enabled patients ... a median time of 1.7 hours between administration ...
(Date:9/1/2015)... , Belgium , Sept. 1, 2015 /PRNewswire/ ... sciences company focused on developing blood-based diagnostic tests for a ... that its Chief Executive Officer, Cameron Reynolds , is ... Healthcare Conference, which is being held September 9-10, 2015 in ... meetings all day on September 10. Wells ...
(Date:9/1/2015)... 2015   Ivenix Inc. , a medical ... closed on a $42M round of equity financing ... Partners, CICA, Inc., Easterly Capital, Fidelity Biosciences, and ... This financing will support the company,s efforts to ... LLC acted as the exclusive placement agent for ...
Breaking Medicine Technology:New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
... shows that,polyunsaturated fatty acids (PUFAs), mainly the omega-3s ... function and total parenteral,nutrition (TPN). The June 2008 ... new findings in these areas., One study ... an omega-3 PUFA, and arachidonic acid, an omega-6 ...
... a,division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today,that the ... pediatric,exclusivity for TOPAMAX(R) (topiramate), based on studies submitted ... to investigate the use of TOPAMAX,in pediatric patients ... seizures., In addition to granting pediatric exclusivity, ...
Cached Medicine Technology:Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 ... of plastic surgeries conducted each year on teenagers, quoting a New York City-area ... Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to ...
(Date:9/1/2015)... ... 01, 2015 , ... September is National Prostate Cancer Awareness Month and Florida ... men each year in the United States. , Prostate cancer is to men what ... affecting 1 in 7 men. One new case occurs every 2.3 minutes and a ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Administration (FDA) for the treatment of androgenic alopecia in adults, announces Miami-based medical ... laser therapy cap, while also demonstrating its safety when used at home to ...
(Date:9/1/2015)... ... , ... Earth Brands, ( http://www.earthbrands.com ) a comfort-meets-fashion women’s ... buys an Earth Brand shoe will be given an opportunity to plant a ... a nonprofit dedicated to planting more trees. Earth Brands products represent contemporary designs ...
(Date:9/1/2015)... ... 01, 2015 , ... ProRehab Physical Therapy , Louisville’s ... with Apex Physical Therapy (Apex) is official as of August 26, ... and empathetic care to local residents from their combined eight locations throughout Louisville. ...
Breaking Medicine News(10 mins):Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3
... a handful of nutrient-rich dried plums each day help ... in postmenopausal women with osteoporosis or osteoarthritis?// - ... State University College of Human Sciences means to find ... is the principal investigator and a nationally recognized expert ...
... of Medicine have demonstrated the potential of a new ... cholesterol// levels. ,The findings are in the ... (NEJM). In this study, patients with homozygous familial hypercholesterolemia ... a remarkable 51% reduction in low-density lipoprotein (LDL) or ...
... of exercise is lethal for the liver, much more than ... characterized by collection of fat around the liver. The disease ... or cirrhosis or even cancer of the liver. ... clue to maintaining a healthy liver is to engage in ...
... published in the December 2006 issue of the Journal of ... Research Center at The Miriam Hospital and Brown Medical School, ... likely to skip breakfast and increase their fast food consumption ... gain. ,"Since the transition from adolescence to adulthood ...
... found to be deficient in nutrients or calories,// and may ... in the province, researchers from University of Ontario said. ... examined 180 food hampers, sourced from a well established food ... per cent of the hampers, meant to last three days, ...
... Jane Carlton of the New York University School of Medicine, ... The one-celled bacterium is the causal organism of ... and more severe among women. The infection is spread through ... ,In addition to causing uncomfortable itching in the genital ...
Cached Medicine News:Health News:Can Prunes Reverse Bone Loss After Menopause? 2Health News:Can Prunes Reverse Bone Loss After Menopause? 3Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 2Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 3Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 2Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 3
... This test device is ... detection of IgG and IgM ... human serum. The test is ... for diagnosis of Dengue viral ...
... intended for the immunochromatographic, qualitative determination ... Strip Gonorrhea is based on the ... determination of gonorrhea antigen in the ... system as an aid in the ...
The Smart Check Syphilis Device is a qualitative membrane device based immunoassay for the detection of TP (Treponema Pallidum) antibodies in whole blood/serum/plasma. For professional in vitro diagn...
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu...
Medicine Products: